TLC-2716
- Generic Name
- TLC-2716
A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants
- First Posted Date
- 2022-08-02
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- OrsoBio, Inc
- Target Recruit Count
- 100
- Registration Number
- NCT05483998
- Locations
- 🇳🇿
OrsoBio Research Site, Auckland, New Zealand
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath